In this episode of EyeCan, we sit down with Dr. Lauren Dalvin, an expert in ocular oncology, to explore the complexities of uveal melanoma and ocular tumors. Dr. Dalvin, an Associate Professor of Ophthalmology at Mayo Clinic, brings her extensive experience in patient-centered research, including groundbreaking work in drug discovery and radiation retinopathy. With over 175 peer-reviewed publications and leadership roles in major ophthalmic organizations, she is at the forefront of advancing eye cancer care through multidisciplinary collaboration and translational research. Tune in as we discuss the latest developments in the field and what they mean for patients and clinicians alike.

With your hosts, Dr. Heather O'Donnell and Dr. Hady Saheb.
Written and directed by Kim Tytler.
Produced by John Allaire of Allaire Strategic Works.
  
The EyeCan Podcast is made possible by support from Bayer.

Show notes:

Canadian Journal of Ophthalmology – Special issue: Ocular Oncology
https://www.canadianjournalofophthalmology.ca/content/ocularoncology

 Patient-derived organoid models
https://pubmed.ncbi.nlm.nih.gov/39601636/

 Uveal Melanoma
https://www.mayoclinic.org/diseases-conditions/eye-melanoma/symptoms-causes/syc-20372371

A Cure in Sight - Independent Organization for Ocular Melanoma for Patients and Research
https://acureinsight.org/

Comments about EyeCan? Contact [email protected] and we’ll get back to you soon!
Listening to EyeCan counts for unaccredited MOC credits. You may claim 0.5 credits per hour under Section 2 (Individual Learning) as “Educational content review”, up to 30 credits per year.